Reassessment of diagnostic criteria in cutaneous lymphocytic infiltrates
Keywords:
Cutaneous T-cell lymphoma, Pseudolymphoma, Mycosis fungoides, Immunohistochemistry, Differential diagnosisAbstract
CONTEXT: Non-specific lymphocytic infiltrates of the skin pose difficulties in daily practice in pathology. There is still a lack of pathognomonic signs for the differential diagnosis between benign and malignant lymphocytic infiltrates. OBJECTIVE: To evaluate the morphological and immunohistochemical profile of lymphocytic infiltrations of the skin according to clinical outcome. TYPE OF STUDY: Retrospective; histopathological and immunohistochemical analysis. SETTING: Referral center, university hospital. SAMPLE: 28 cases of lymphocytic infiltrates of difficult differential diagnosis selected from the records. MAIN MEASUREMENTS: Eighteen histological variables and the immunophenotypic profile were assessed using the CD4, CD8, CD3, CD20 and CD30 lymphoid markers and compared to subsequent follow-up. RESULTS: The most common diagnoses were: initial mycosis fungoides (eight cases) and drug reactions (five cases). Single morphological variables did not discriminate between benign and malignant infiltrates except for the presence of Pautrier-Darier’s microabscesses, which were found only in mycosis fungoides (p = 0.015). Patterns of superficial and deep infiltration (p = 0.037) and also the presence of eosinophils (p = 0.0207) were more frequently found in benign lymphocytic infiltrates. Immunohistochemical profile of T-cell subsets showed overlap between benign and malignant infiltrates with a predominance of CD4-positive (helper) lymphocytes in the majority of cases. CONCLUSIONS: A combination of clinical and histological features remains the most reliable approach for establishing a definite diagnosis in cases of lymphoid skin infiltrates.
Downloads
References
Elder D, Elenitsas R, Jawarsky C, Johnson B. Lever’s Histopathology of the Skin. 8th edition. Philadelphia: Lippincott-Raven; 1997.
Weedon D. Skin Pathology. London: Churchill Livingstone; 1997.
Ming M, LeBoit PE. Can dermatopathologists reliably make the diagnosis of mycosis fungoides? If not, who can? Arch Dermatol. 2000;136(4):543-6.
Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol. 2000;24(1):40-50.
Ackerman AB. Histologic Diagnosis of Inflammatory Skin Diseases. 2nd edition. Baltimore: Williams & Wilkins; 1997.
Diaz-Cascajo C. Strong immunoexpression of the monoclonal antibody CD-30 in lymphocytic infiltrates of the skin not by itself evidence for diagnosing malignant lymphoma. Am J Dermatopathol. 2001;23(1):79-80.
Hudson AR, Smoller BR. Immunohistochemistry in diagnostic dermatopathology. Dermatol Clin. 1999;17(3):667-89.
Izban KF, Hsi ED, Alkan S. Immunohistochemical analysis of mycosis fungoides on paraffin-embedded tissue sections. Mod Pathol. 1998;11(10):978-82.
Glusac EJ, Shapiro PE, McNiff JM. Cutaneous T-cell lym- phoma. Refinement in the application of controversial histologic criteria. Dermatol Clin. 1999;17(3):601-14.
Nuckols JD, Shea CR, Horenstein MG, Burchette JL, Prieto VG. Quantitation of intraepidermal T-cell subsets in formalin- fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol. 1999;26(4):169-75.
Rijlaarsdam JU, Scheffer E, Meijer CJ, Willemze R. Cutane- ous pseudo-T-cell lymphomas. A clinicopathologic study of 20 patients. Cancer. 1992;69(3):717-24.
Haeffner AC, Smoller BR, Zepter K, Wood GS. Differentiation and clonality of lesional lymphocytes in small plaque parapso- riasis. Arch Dermatol. 1995;131(3):321-4.
LeBoit PE. Variants of mycosis fungoides and related cutaneous T-cell lymphomas. Semin Diagn Pathol. 1991;8(2):73-81.
Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Re- search and Treatment of Cancer. Blood. 1997;90(1):354-71.
Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol. 1995;19(12):1423-30.
Yoshino T, Mukuzono H, Aoki H, et al. A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues. Am J Pathol. 1989;134(6):1339-46.
Sams WM, Lynch PJ. Principles and Practice of Dermatology. 2nd edition. Singapore: Churchill Livingstone; 1996.
Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol. 1988;10(6):469-77.
Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoi- des/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol. 1994;18(7):645-67.
Beljaards RC, Kaudewitz P, Berti E, et al. Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients. Cancer. 1993;71(6):2097-104.
Segal GH, Kjeldsberg CR, Smith GP, Perkins SL. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases. Am J Clin Pathol. 1994;102(3):292-8.
Cespedes YP, Rockley PF, Flores F, Ruiz P, Kaiser MR, Elgart GW. Is there a special relationship between CD30-positive lymphoproliferative disorders and epidermal proliferation? J Cutan Pathol. 2000;27(6):271-5.
Bakels V, van Oostveen JW, van der Putte SC, Meijer CJ, Wil- lemze R. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas. Am J Pathol. 1997;150(6):1941-9.
